Department of Public Policy, University of North Carolina at Chapel Hill, Chapel Hill.
Department of Pediatrics, University of Colorado School of Medicine, Aurora.
JAMA Pediatr. 2018 Mar 1;172(3):287-293. doi: 10.1001/jamapediatrics.2017.4931.
In this article, we examine the status of the National Institutes of Health (NIH) pediatric research portfolio between start of federal fiscal year (FY) 1992 and end of FY 2015. The NIH experienced the greatest mean annual growth rate during the "doubling era" (FY 1998-2003): both the NIH budget (13.5%) and pediatric research portfolios (11.5%) increased annually by double digits. However, in the "postdoubling" era (FY 2004-2009), both the NIH (2.0%) and pediatric (-0.2%) mean annual growth rates decreased dramatically. In the most recent era (FY 2010-2015), the NIH mean annual growth rate has been flat (-0.1%) and pediatric research funding has posted very modest gains (3.5%) without accounting for 1-time increases under the 2009 American Recovery and Reinvestment Act. We offer recommendations to protect against further erosion of the pediatric research portfolio because continuation of these trends will have a negative effect on the health of children during their childhood and as adults. As capacity to conduct basic and applied research is further constrained, it will be a challenge for pediatric researchers to do more with less and less.
本文研究了 1992 财年开始到 2015 财年结束期间美国国立卫生研究院(NIH)儿科研究投资组合的状况。NIH 在“翻倍时代”(1998-2003 财年)经历了最大的年均增长率:NIH 预算(13.5%)和儿科研究投资组合(11.5%)每年都以两位数增长。然而,在“翻倍后时代”(2004-2009 财年),NIH(2.0%)和儿科(-0.2%)的年均增长率都大幅下降。在最近的时代(2010-2015 财年),NIH 的年均增长率持平(-0.1%),儿科研究资金仅略有增长(3.5%),没有计入 2009 年《美国复苏与再投资法案》下的一次性增长。我们提出了一些建议,以防止儿科研究投资组合进一步减少,因为这些趋势的延续将对儿童的健康产生负面影响,无论是在儿童时期还是成年后。随着进行基础和应用研究的能力进一步受到限制,儿科研究人员将面临用更少的资源做更多事情的挑战。